Melanie Ivarsson OBE

Examiner
DISC Type : sc

Founder and CEO at Ridgelight Consulting Ltd

United Kingdom

Overview

Dr. Melanie Ivarsson is a biotech executive with over 25 years of experience in the life sciences industry, holding leadership roles at Moderna, Pfizer, and Takeda. She holds a PhD from the University of Bristol and an MBA from MIT Sloan, and she specializes in global clinical development and strategic operational projects.

Her professional passions include driving innovation in healthcare, particularly through cross-functional collaboration and new technologies. She frequently speaks on panels about the future of the life sciences sector and has a keen interest in accelerating drug development for rare diseases and improving public health through large-scale clinical programs.

She was awarded an OBE (Officer of the Order of the British Empire) in the 2022 New Years Honours List for her services to public health, particularly for leading the clinical trials for one of the first Covid-19 vaccines at Moderna.

Personality Overview

Status Quo Seeker

Late Adopter

Unexpressive

They are thorough and always follow a systematic approach.  They do not like taking risks at all and go for proven options in the end. They are heavily focused on quality and prefer doing things the right way, even if it takes time.

Topics They Care About

AI in Drug Development
Serves on the advisory board for PhaseV, an AI-driven clinical trial company, and frequently discusses how AI can accelerate drug development and redefine how trials are executed.
Rare Disease Therapies
Has a background in developing treatments for rare conditions like Huntington's Disease and lysosomal storage disorders, and continues to express excitement for advancing research in these areas.
UK Life Sciences
Actively participates in high-level discussions and panels about the UK's strategy and future in the global life sciences industry, as seen in her recent speaking engagements.

Media Appearances

Melanie has no verified media appearances

Work History

8-2025
Founder and CEO at Ridgelight Consulting Ltd
9-2025
Board Member at Protas
7-2025
Scientific Advisory Board member at PhaseV
1-2022
Non Executive Director at LoQus23 Therapeutics Ltd
11-2024 - 6-2025
Advisor at Moderna

Education

2017 - 2019
Master of Business Administration - MBA from MIT Sloan School of Management
PhD from University of Bristol

More Information

Social Presence :

Prographics :

Exp : 5 Location : United Kingdom Job Level : Leadership Designation : Founder and CEO at Ridgelight Consulting Ltd
URL has been copied!

Insights For Selling To Melanie

During A Call Or A Meeting

DO's

  • Expect them to be slow and cautious, encourage them to ask more questions
  • Be firm in your communication and stay in control
  • Ask them which other stakeholders would be important for this purchase decision

DONT's

  • Don't push them too hard to make fast decisions, give them time
  • Don't use phrases like 'do not worry', 'i promise' etc.
  • Don't rely on relationship building even if they act pleasantly

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Melanie is

  • Adoption by others is very important to them, followed by confidence in ROI.
  • Will you ever get a clear answer from Melanie

  • They don’t say no often, they push out the decisions or keep going around in circles.

Insights For Deal Planning

    How fast (or slow) will Melanie move?

  • They don't like to hasten, so their speed of decision-making may be slow.
  • Can Melanie take some risk or not?

  • They have little willingness to take risks, and prefer making calculated decisions.

You And Melanie

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.